Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.
Ting Martin MaYilun SunShawn MaloneMack RoachDavid P DearnaleyThomas M PisanskyFelix Y FengHoward M SandlerJason Alexander EfstathiouIsabel SyndikusEmma C HallAlison C TreeMatthew R SydesClaire CruickshankSoumyajit RoyMichel BollaPhilippe MaingonTheo De ReijkeAbdenour NabidNathalie CarrierLuis SouhamiAlmudena ZapateroAraceli GuerreroAna AlvarezCarmen Gonzalez San-SegundoXavier MaldonadoTahmineh RomeroMichael L SteinbergLuca F ValleMatthew B RettigNicholas G NickolsJonathan E ShoagRobert E ReiterNicholas G ZaorskyAngela Y JiaJorge A GarciaDaniel E SprattAmar U Kishannull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
ADT sequencing exhibits a significant impact on clinical outcomes with a significant interaction with field size. Concurrent/adjuvant ADT should be the standard of care where short-term ADT is indicated in combination with PORT.
Keyphrases
- prostate cancer
- early stage
- locally advanced
- single cell
- healthcare
- radical prostatectomy
- palliative care
- radiation therapy
- quality improvement
- radiation induced
- squamous cell carcinoma
- rectal cancer
- robot assisted
- pain management
- randomized controlled trial
- clinical trial
- stem cells
- bone marrow
- chronic pain
- laparoscopic surgery
- health insurance
- study protocol